Elisa Lázaro‐Ibáñez
AstraZeneca (Australia)(AU)AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Extracellular vesicles in disease, MicroRNA in disease regulation, RNA Interference and Gene Delivery, Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells(2015)596 cited
- → Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content(2015)309 cited
- → Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: Apoptotic bodies, microvesicles, and exosomes(2014)276 cited
- → DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients(2016)266 cited
- → Selection of Fluorescent, Bioluminescent, and Radioactive Tracers to Accurately Reflect Extracellular Vesicle Biodistribution in Vivo(2021)242 cited
- → DNA analysis of low‐ and high‐density fractions defines heterogeneous subpopulations of small extracellular vesicles based on their DNA cargo and topology(2019)188 cited
- → Extracellular vesicles induce minimal hepatotoxicity and immunogenicity(2019)187 cited
- → Quantification of protein cargo loading into engineered extracellular vesicles at single‐vesicle and single‐molecule resolution(2021)184 cited
- → A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery(2021)126 cited
- → Engineered Cas9 extracellular vesicles as a novel gene editing tool(2022)110 cited